Drug discovery relies on the knowledge of not only drugs and targets, but also the
comparative agents and targets. These include poor binders and non-binders for developing …

Single-cell proteomics (SCP) has emerged as a powerful tool for detecting cellular heterogeneity,
offering unprecedented insights into biological mechanisms that are masked in bulk …

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a severe and rapidly evolving epidemic. Now, although a few …

The success of protein engineering and design has extensively expanded the protein space,
which presents a promising strategy for creating next-generation proteins of diverse …

ANPELA is widely used for quantifying traditional bulk proteomic data. Recently, there is a
clear shift from bulk proteomics to the single‐cell ones (SCP), for which powerful cytometry …

Individual variations in drug efficacy, side effects and adverse drug reactions are still
challenging that cannot be ignored in drug research and development. The aim of …

Drug discovery and development affects various aspects of human health and dramatically
impacts the pharmaceutical market. However, investments in a new drug often go …

Natural product (NP) has a long history in promoting modern drug discovery, which has
derived or inspired a large number of currently prescribed drugs. Recently, the NPs have …

RNAs play essential roles in diverse physiological and pathological processes by interacting
with other molecules (RNA/protein/compound), and various computational methods are …

In a drug formulation (DFM), the major components by mass are not Active Pharmaceutical
Ingredient (API) but rather Drug Inactive Ingredients (DIGs). DIGs can reach much higher …